Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous ketamine versus ropivacaine for postoperative pain after laparoscopic cholecystectomy
IRCT20250107064314N2Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, ropivacaine and morphine in postoperative pain (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Postoperative pain intensity, Morphine consumption and 3 more. Started Sep 2026; status: recruiting.
02
Drugs
ketamineropivacainemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20250107064314N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250107064314N2.